CompletedPhase 2NCT04970355
Efficacy of Erenumab in Chronic Cluster Headache
Studying Trigeminal autonomic cephalalgia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Charite University, Berlin, Germany
- Principal Investigator
- Uwe Reuter, MDCharite University, Berlin, Germany
- Intervention
- Erenumab(biological)
- Enrollment
- 101 target
- Eligibility
- 18-64 years · All sexes
- Timeline
- 2021 – 2023
Study locations (11)
- LMU Klinikum München, München, Bavaria, Germany
- Kopfschmerzzentrum Frankfurt, Frankfurt am Main, Hesse, Germany
- Vitos - Orthopädische Klinik gGmbH, Kassel, Hesse, Germany
- Universitätsmedizin Greifswald, Greifswald, Mecklenburg-Vorpommern, Germany
- Universitätsklinikum Rostock, Rostock, Mecklenburg-Vorpommern, Germany
- Praxis für Neurologie, Nervenheilkunde, Psychosomatik, Essen, North Rhine-Westphalia, Germany
- Universitätsklinikum Essen, Essen, North Rhine-Westphalia, Germany
- Universitätsklinik Dresden, Dresden, Saxony, Germany
- Universitätsklinikum Halle, Halle, Saxony-Anhalt, Germany
- Schmerzklinik Kiel - Migräne- und Kopfschmerzzentrum, Kiel, Schleswig-Holstein, Germany
- Charité Universitätsmedizin Berlin, Berlin, Germany
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04970355 on ClinicalTrials.govOther trials for Trigeminal autonomic cephalalgia
Additional recruiting or active studies for the same condition.